CLL: Risk Factors, Resources and Research

Ann LaCasce, MD

Join Alicia and Lizette from The Leukemia and Lymphoma Society as they speak with Dr. Ann LaCasce, Program Director of the Dana-Farber/ Partners CancerCare Fellowship, the largest hematology/oncology training program in the country. On this episode, Dr. LaCasce explains the difference between chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), CLL and its connection with Agent Orange exposure, resources available for Veterans, current and emerging therapies, clinical trials and the importance of medication adherence. Dr. LaCasce shares her excitement for what is to come for CLL treatment and her appreciation for fellow providers around the world, who work to move science forward as they continue to learn from each other. 

You can listen to our other episode with Dr. LaCasce about CLL here.

Support for this episode provided by Pharmacyclics.

Please like and share:

2 Comments

    1. Hi Melinda,

      Thank you so much for listening! You can visit http://www.LLS.org/booklets to access all of our free publications. If you have any questions about our booklets and any of our other resources, you can speak one-on-one with one of our Information Specialists. Our Information Specialist are master’s level oncology social workers, nurses and health educators, who can can assist patients and caregivers through cancer treatment, financial and social challenges and give accurate, up-to-date disease, treatment and support information.

Leave a Comment

Your email address will not be published. Required fields are marked *